Rheumatology

On a busy night in the ED, the difference between a controlled resuscitation and a crisis often depends on the […]

DALLAS — Leaders of several medical organizations came together at the American College of Lifestyle of Medicine’s annual conference to

CHICAGO — Using AI in rheumatology was an important discussion topic at ACR Convergence 2025, according to Micaela F. Bayard,

DALLAS — Wearable technology offers health care providers an opportunity for more personalized care, as long as it is used

DALLAS — What is happiness? According to Laurie R. Santos, MA, PhD, social scientists define it as “the idea that

DALLAS — American College of Lifestyle of Medicine membership has tripled since 2019, growing to more than 15,000 members across

NEW YORK — Healio AI offers physicians a new AI tool that is crafted for their needs and could offer

SAN DIEGO — AI may foster communication and provide health care professionals with a new sense of purpose, according to

SAN ANTONIO — Teaching patients with juvenile idiopathic arthritis about their disease and asking them to “teach back” what they

SAN DIEGO — Physicians should maintain agency in shaping the future of AI to augment their clinical workflow and medical

SAN DIEGO — The American Board of AI in Medicine educates health care professionals about the role of AI in

This year, physicians across the U.S. grappled with levels of stress and anxiety comparable to those experienced during the pandemic,

Every emergency medicine physician has a case that lingers long after the shift ends — the patient who appeared stable,

More than 60% of health care professionals report having trust and organizational support for using AI in their practices, yet

CHICAGO — Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to

CHICAGO — Deucravacitinib reduces circulating proteins associated with kidney dysfunction in patients with systemic lupus erythematosus, according to data presented

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the

CHICAGO — Corticosteroid plus lidocaine injections failed to show benefit over lidocaine-only injections in knee osteoarthritis, according to data presented

CHICAGO — Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of long COVID

CHICAGO — Patients with knee osteoarthritis who received lorecivivint injections experienced clinically meaningful improvements in pain and function, according to

CHICAGO — Chronic rheumatic diseases may impose greater long-term financial burdens than cancer, particularly for younger adults, according to data

CHICAGO — The use of glucocorticoids, at doses prescribed by rheumatologists, for inflammatory arthritis resulting from checkpoint inhibitors may not

CHICAGO — Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells rather

CHICAGO — Psoriatic arthritis disease activity levels appear to increase on average during perimenopause before decreasing slightly after menopause, according

CHICAGO — Patients with lupus nephritis who received GLP-1 receptor agonists exhibited lower risk for mortality and slower kidney disease

CHICAGO — Medical board-style questions created by AI and large language models were often grammatically correct but factually inaccurate, according

CHICAGO — CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory systemic